ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Publication Type:

Journal Article


The New England journal of medicine, Volume 369, Issue 6, p.529-39 (2013)


2013, August 2013, Biological Markers, Graft vs Host Disease, hematopoietic stem cell transplantation, Humans, Middle Aged, Public Health Sciences Division, Receptors, Cell Surface, RECURRENCE, Risk Assessment, Risk Factors, Transplantation, Homologous


No plasma biomarkers are associated with the response of acute graft-versus-host disease (GVHD) to therapy after allogeneic hematopoietic stem-cell transplantation.